Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Neurologie C, 69677, Bron Cedex, France.
Hospices Civils de Lyon, Hôpital Cardiovasculaire Louis Pradel, Fédération D'endocrinologie, Maladies métaboliques, diabète Et Nutrition, Groupement Hospitalier Est, 28 avenue Doyen Lépine, 69677, Bron Cedex, France.
J Neurol. 2020 Feb;267(2):531-542. doi: 10.1007/s00415-019-09608-2. Epub 2019 Nov 7.
Phenylketonuria (PKU) is a rare autosomal recessive disease characterised by high plasma phenylalanine levels inducing, if untreated, serious neurological manifestations in children but also, rarely, in adults who stopped their diet. The objective of the study was to describe the neurological manifestations observed in adults with PKU.
We analysed cases reported in French reference centres for inborn errors of metabolism and cases already reported in the literature.
We report 8 new cases of neurological manifestations and 22 cases in the literature, which occurred in adult PKU patients, associated with chronic or rapid increase of phenylalanine levels, mostly when strict low-phenylalanine diet was stopped early in life. Neurological symptoms consisted in cerebellar ataxia, tremor, brisk reflexes, visual loss, sensory manifestations, and/or headaches. Visual loss was more frequent in the new cases (4/8) of the present series than in the literature (4/22). These neurological complications were associated with leucopathy on brain magnetic resonance imaging (27/29). The start of a low-phenylalanine diet improved or fully reversed neurological manifestations, even in patients with late diagnosis during adulthood.
Neurological manifestations can complicate PKU in adult patients with elevated phenylalanine levels, after long or short period of diet discontinuation. Neurologists should be aware of this diagnosis, and measure phenylalaninemia in case of neurological symptoms associated with non-specific leucopathy on brain MRI. PKU patients should be systematically encouraged to continue their diet and their medical follow-up to avoid neurological complications.
苯丙酮尿症(PKU)是一种罕见的常染色体隐性遗传病,其特征是血液中苯丙氨酸水平升高,如果不治疗,会导致儿童出现严重的神经表现,但也会导致少数停止饮食的成年人出现这种情况。本研究的目的是描述成人 PKU 患者的神经表现。
我们分析了法国代谢性遗传病参考中心报告的病例和文献中已报告的病例。
我们报告了 8 例新的神经表现病例和文献中的 22 例病例,这些病例发生在成年 PKU 患者中,与慢性或快速升高的苯丙氨酸水平有关,主要发生在早期停止严格低苯丙氨酸饮食时。神经症状包括小脑共济失调、震颤、反射亢进、视力丧失、感觉表现和/或头痛。在本研究系列的 4/8 例新病例中,视力丧失比文献中的 4/22 例更常见。这些神经并发症与脑磁共振成像上的白质病变有关(27/29)。低苯丙氨酸饮食的开始改善或完全逆转了神经表现,即使在成年后诊断较晚的患者中也是如此。
在长期或短期停止饮食后,升高的苯丙氨酸水平会使成年 PKU 患者出现神经表现。神经科医生应该意识到这一诊断,如果存在与脑 MRI 上非特异性白质病变相关的神经症状,应测量苯丙氨酸水平。应系统地鼓励 PKU 患者继续饮食和接受医学随访,以避免神经并发症。